SCHEMBL19082173

SCHEMBL19082173

c1cc(-c2ccc3ccccc3c2)cc(-c2c3ccccc3c(-c3cc4sc5c6ccccc6ccc5c4c4sc5ccccc5c34)c3ccccc23)c1

nearest known ligand 0.39

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
CYP1A1 P04798 6/20 0.39
CYP1B1 Q16678 6/20 0.39
CYP1A2 P05177 4/20 0.36
HSD17B1 P14061 2/20 0.34
HSD17B2 P37059 2/20 0.34
S1PR5 Q9H228 7/20 0.33
S1PR4 O95977 6/20 0.33
PTPN1 P18031 1/20 0.33
ALOX5 P09917 1/20 0.33
NQO1 P15559 1/20 0.32
NQO2 P16083 1/20 0.32
F9 P00740 1/20 0.31
CYP3A4 P08684 1/20 0.30
CYP2D6 P10635 1/20 0.30
CYP2C9 P11712 1/20 0.30
CYP2B6 P20813 1/20 0.30
CYP2C19 P33261 1/20 0.30
MAPK9 P45984 1/20 0.30
MAPK14 Q16539 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17945215 0.95 HSD17B1 (0.35) CYP1A1CYP1B1CYP1A2HSD17B1HSD17B2
SCHEMBL17945205 0.91 PTPN1 (0.37) CYP1A1CYP1B1S1PR5S1PR4PTPN1
SCHEMBL19082293 0.90 CYP1A1 (0.36) CYP1A1CYP1B1CYP1A2S1PR5S1PR4
SCHEMBL17944633 0.90 ALOX5 (0.38) CYP1A1CYP1B1CYP1A2HSD17B1HSD17B2
SCHEMBL19082311 0.89 CYP1A1 (0.39) CYP1A1CYP1B1CYP1A2HSD17B1HSD17B2
SCHEMBL19082383 0.89 ALOX5 (0.38) CYP1A1CYP1B1CYP1A2S1PR5S1PR4
SCHEMBL19082347 0.88 CYP1A1 (0.40) CYP1A1CYP1B1CYP1A2S1PR5S1PR4
SCHEMBL19082154 0.88 CYP1A1 (0.42) CYP1A1CYP1B1CYP1A2PTPN1ALOX5
SCHEMBL17945699 0.88 PTPN1 (0.36) CYP1A1CYP1B1CYP1A2HSD17B1HSD17B2
SCHEMBL19082101 0.88 CYP1A1 (0.44) CYP1A1CYP1B1CYP1A2PTPN1ALOX5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10553800-B2 Condensed cyclic compound and an organic light-emitting device including the same SAMSUNG DISPLAY CO., LTD. (KR) 2020-02-04 US disclosed
US-20170194572-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2017-07-06 US disclosed
US-20170194572-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2017-07-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10553800-B2 Condensed cyclic compound and an organic light-emitting device including the same CRY1, CRY2, CCNT1 CYP1A1 184/4885CYP1B1 260/4885CYP1A2 659/4885
US-20170194572-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME CRY1, CRY2, CCNT1 CYP1A1 184/4885CYP1B1 260/4885CYP1A2 659/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.